Pyruvate Dehydrogenase E2 Deficiency

Description

Pyruvate dehydrogenase E2 deficiency is a very rare form of pyruvate dehydrogenase deficiency (PDHD, see this term) characterized by variable lactic acidosis and neurological dysfunction, mainly appearing during childhood.

Clinical Features

Top most frequent phenotypes and symptoms related to Pyruvate Dehydrogenase E2 Deficiency

  • Intellectual disability
  • Global developmental delay
  • Generalized hypotonia
  • Microcephaly
  • Ataxia
  • Nystagmus
  • Ptosis
  • Motor delay
  • Hyperreflexia
  • Dystonia

And another 15 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Pyruvate Dehydrogenase E2 Deficiency Is also known as dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex deficiency, lactic acidemia due to defect of e2 lipoyl transacetylase of the pyruvate dehydrogenase complex, pyruvate dehydrogenase complex component e2 deficiency, dihydrolipoyll.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Pyruvate Dehydrogenase E2 Deficiency Recommended genes panels

Panel Name, Specifity and genes Tested/covered
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
DLAT Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

DLAT
Specificity
100 %
Genes
100 %
DLAT Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

DLAT
Specificity
100 %
Genes
100 %
DLAT Sequence Analysis.

By Baylor Miraca Genetics Laboratories (United States).

DLAT
Specificity
100 %
Genes
100 %
DLAT Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories (United States).

DLAT
Specificity
100 %
Genes
100 %
Comprehensive Mitochondrial Metabolic Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).

BCS1L, SCO1, SCO2, SDHB, SDHC, SDHD, SLC22A5, SLC25A13, SLC25A15, SLC25A3, SLC25A4, BTD, SUCLA2, SUCLG1, SURF1, TAZ, TWNK, TCN2, TFAM, TIMM8A , (...)

View the complete list with 173 more genes
Specificity
1 %
Genes
100 %
Dystonia.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).

SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SPR, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX , (...)

View the complete list with 57 more genes
Specificity
2 %
Genes
100 %
Movement Disorders Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).

SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1 , (...)

View the complete list with 72 more genes
Specificity
2 %
Genes
100 %

You can get up to 36 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

MESH OMIM ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like UNCOMBABLE HAIR SYNDROME 1; UHS1 PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1 DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD EHLERS-DANLOS SYNDROME, TYPE VI; EDS6 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32 SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION